US Supplement Firm Warnings Up, Enforcement Tools Idle, Hemp and NAC Still In Limbo

FDA “didn’t really take any steps towards a resolution” in 2021 and is “mostly content” with enforcement discretion allowing sales of non-drug products which contain cannabinoids and other hemp-derive ingredients, says Stuart Pape, of Polsinelli PC, during a recent Food and Drug Law Institute conference.